Cue Biopharma Inc (NASDAQ:CUE)
| 2.38 Delayed Data As of Dec 01 |  -0.1199 / -4.80%Today’s Change | 1.70 Today|||52-Week Range 5.12 | -16.49% Year-to-Date |
Latest CUE News | Press Releases
No recent news for Cue Biopharma Inc.
Today’s Trading
| Previous close | 2.50 |
| Today’s open | 2.40 |
| Day’s range | 2.25 - 2.41 |
| Volume | 19,162 |
| Average volume (3 months) | 315,359 |
| Market cap | $104.2M |
Data as of 3:59pm ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | -5.34% |
| Earnings growth (this year) | +13.09% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | -91.67% |
| P/E ratio | NM |
| Price/Sales | 81.59 |
| Price/Book | 1.51 |
Competitors
Data as of 3:59pm ET, 12/01/2023
Financials
| Next reporting date | March 27, 2024 |
| EPS forecast (this quarter) | -$0.35 |
| Annual revenue (last year) | $1.2M |
| Annual profit (last year) | -$53.0M |
| Net profit margin | -4,257.09% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
